Rare cancer survivorship research funding at the National Institutes of Health (NIH), 2017 to 2023.
| Publicado en: | Cancer Causes & Control Vol. 36; no. 6; pp. 587 - 595 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Jun2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=185350346&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 185350346 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09575243 ODX jtl: Cancer Causes & Control issn: 09575243 maglogo: N pubinfo: dt: Jun2025 vid: 36 iid: 6 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 185350346 182360460 10.1007/s10552-025-01959-8 185350346 ppf: 587 ppct: 8 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Rare cancer survivorship research funding at the National Institutes of Health (NIH), 2017 to 2023. aug: au: Gallicchio, Lisa Mollica, Michelle Tesauro, Gina Doose, Michelle Guida, Jennifer L. Maher, Molly E. Tonorezos, Emily affil: https://ror.org/040gcmg81 Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|